Literature DB >> 27308018

Crystal structure of (1S*,2R*)-7-benz-yloxy-2-methyl-3-tosyl-2,3,4,5-tetra-hydro-1H-3-benz-azepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists.

Bastian Tewes1, Bastian Frehland1, Roland Fröhlich2, Bernhard Wünsch3.   

Abstract

In the title compound, C25H27NO4S, which crystallized as a racemate, the relative configuration of the adjacent OH and CH3 groups on the azepine ring is trans. The seven-membered azepin ring has a chair-like conformation. The planar aromatic rings of the benzyl and tosyl-ate moiety are inclined to the planar 3-benzazepine ring by 78.39 (15) and 77.03 (14)°, respectively, and to each another by 13.82 (15)°. In the crystal, mol-ecules are linked via O-H⋯O and C-H⋯O hydrogen bonds, forming double-stranded chains along the a-axis direction. The chains are linked via C-H⋯π inter-actions, forming a three-dimensional architecture.

Entities:  

Keywords:  GluN2B antagonists; NMDA receptor antagonists; conformational restriction; crystal structure; hydrogen bonding; ifenprodil analogs; relative configuration; tetra­hydro-3-benzazepines

Year:  2016        PMID: 27308018      PMCID: PMC4908544          DOI: 10.1107/S2056989016005855

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Inhibition of overactive N-methyl-d-aspartate (NMDA) receptors represents a promising strategy for the treatment of acute (e.g. stroke, epilepsy, traumatic brain injury) and chronic neuronal disorders (e.g. neuropathic pain, depression, Alzheimer’s and Parkinson’s disease) (Bräuner-Osborne et al., 2000 ▸; Kew & Kemp, 2005 ▸; Paoletti et al., 2013 ▸; Wu & Zhou, 2009 ▸). The NMDA receptor consists of four proteins (hetero­tetra­mer), which form a cation channel allowing the penetration of Ca2+ and Na+ ions into the neuron (Furukawa et al., 2005 ▸). In particular, NMDA receptors containing the GluN2B subunit are an attractive target for the development of innovative drugs, since the expression of the GluN2B subunit is limited to only a few regions of the central nervous system, including cortex, striatum and hippocampus (Borza & Domány, 2006 ▸; Layton et al., 2006 ▸; Mony et al., 2009 ▸). Moreover, the GluN2B subunit can be addressed selectively by ligands inter­acting with the so-called ifenprodil binding site, which is formed at the inter­face between GluN2B and GluN1 subunits (Karakas et al., 2011 ▸; Paoletti et al., 2013 ▸). The 2-piperidino-1-phenyl­propan-1-ol derivative ifenprodil (Paoletti et al., 2013 ▸; Williams, 2001 ▸) (Fig. 1 ▸) represents the first ligand inter­acting with this binding site at the NMDA receptor. As a result of its poor selectivity and low bioavailability, ifenprodil has not been developed as a drug for clinical use. In order to improve the selectivity and metabolic stability, the flexible β-amino­alcohol substructure of ifenprodil has been incorporated into a rigid tetra­hydro-3-benzazepine ring (Tewes et al., 2010a ▸,b ▸; Schepmann et al., 2010 ▸; Falck et al., 2014 ▸).
Figure 1

Synthesis of GluN2B antagonists including the lead compound ifenprodil and the target compound (S,R)-4. Reagents and reaction conditions: (a) NaBH4, CH3OH, (S,R)-2 50%, (R,R)-3 23%.

Elucidation of the relative configuration

For the synthesis of 3-benzazepine analogs of ifenprodil, we developed a chiral pool synthesis starting with (R)-alanine. In a five step synthesis (Fig. 1 ▸), the central inter­mediate ketone (R)-1 was prepared from (R)-alanine (Tewes et al., 2015 ▸). The reduction of the ketone (R)-1 with NaBH4 led to the diastereomeric alcohols (S,R)-2 and (R,R)-3, which were further transformed into potent GluN2B antagonists by reductive removal of the tosyl group, alkyl­ation with 1-chloro-4-phenyl­butane and finally, hydrogeno­lytic cleavage of the benzyl ether. For example, the phenol (S,R)-4 displays very high affinity towards the ifenprodil binding site of the NMDA receptor (K i = 26 nM) and, moreover, (S,R)-4 is able to reduce the glutamate- and glycine-induced cytotoxicity with an IC50 value of 9.0 nM (Tewes et al., 2015 ▸). The diastereomeric alcohols (S,R)-2 and (R,R)-3 were separated by flash column chromatography and isolated in 50% and 23% yield, respectively. However, as a result of flexibility of the seven-membered tetra­hydro-3-benzazepine ring, it was not possible to assign the relative configuration of the methyl and hy­droxy moiety. Therefore, the main diastereomer (1S,2R)-2 was crystallized and we report herein on its crystal structure.

Structural commentary

The mol­ecular structure of the title compound (1S,2R)-2 is illustrated in Fig. 2 ▸. Since the starting material was not enanti­omerically pure, the compound crystallized as a racemate. However, the relative trans-configuration of the OH and CH3 groups in the 1- and 2-positions on the azepine ring is clearly shown, leading to a trans-configuration for compound (S*,R*)-2. The CH3 and the OH groups adopt an axial orientation in the seven-membered azepine ring which has a chair conformation. The phenyl group of the benzyl moiety (C16–C21) and the phenyl group of the tosyl­ate moiety (C25–C30) are inclined to the benzene ring of the 3-benzazepine ring (C6–C11) by 78.39 (15) and 77.03 (14)°, respectively, and to each another by 13.82 (15)°. In the azepine ring, the bonds between the N atom, N3, and its adjacent C atoms, C2 and C4 [1.483 (3) and 1.480 (3) Å, respectively] are naturally shorter than the corresponding CC bonds [1.509 (4)–1.519 (4) Å]. The exocyclic N3—S22 bond is considerably longer at 1.622 (2) Å. The bond angles within the azepine ring are close to the tetra­hedral angle [106.2 (2)–116.3 (2) °]. Fig. 2 ▸ also shows the tetra­hedral geometry around the S atom, S22, of the sulfon-amide.
Figure 2

The mol­ecular structure of the title compound (1S,2R)-2 with atom labelling. Displacement ellipsoids are drawn at the 30% probability level.

Supra­molecular features

In the crystal, mol­ecules are linked via O—H⋯O and C—H⋯O hydrogen bonds, forming double-stranded chains along the a-axis direction (Table 1 ▸ and Fig. 3 ▸). The chains are linked via C—H⋯π inter­actions (Table 1 ▸), forming a three-dimensional architecture.
Table 1

Hydrogen-bond geometry (Å, °)

Cg1, Cg2 and Cg3 are the centroids of rings C6–C11, C16–C21 and C25–C30, respectively.

D—H⋯A D—HH⋯A DA D—H⋯A
O12—H12⋯O23i 0.832.223.034 (3)169
C2—H2⋯O24ii 0.992.523.265 (3)132
C18—H18⋯Cg3iii 0.942.893.738 (4)150
C20—H20⋯Cg1iv 0.942.833.631 (3)144
C29—H29⋯Cg2v 0.942.763.545 (3)142

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) ; (v) .

Figure 3

A view along the a axis of the crystal packing of the title compound (1S,2R)-2. The hydrogen bonds are shown as dashed lines (see Table 1 ▸); for clarity, H atoms not involved in these inter­actions are omitted.

Synthesis and crystallization

(1 ,2 )-7-Benz­yloxy-2-methyl-3-(4-tos­yl)-2,3,4,5-tetra­hydro-1 -3-benzazepin-1-ol [( )-2] and (1 ,2 )-7-benz­yloxy-2-methyl-3-(4-tos­yl)-2,3,4,5-tetra­hydro-1 -3-benzazepin-1-ol [( )-3] Details of the synthesis of the title compound are illustrated in Fig. 1 ▸. As described for the synthesis of (R,S)-2 and (S,S)-3 (Tewes et al. (2015 ▸), the ketone (R)-1 (5.20 g, 12.0 mmol) was reduced with NaBH4 (909 mg, 23.9 mmol) in CH3OH (125 ml). (S,R)-2 (R f = 0.29): Colourless solid, m.p. 417 K, yield 2.60 g (50%). Purity (HPLC): 98.1%, t R = 22.6 min. [α]D = +1.20 (c = 0.91, CH3OH, 2.1% ee). Spectroscopic data are given in Tewes et al. (2015 ▸). (R,R)-3 (R f = 0.44): Colourless solid, m.p. 425 K, yield 1.20 g (23%). Purity (HPLC): 95.6%, t R = 22.2 min. [α]D = +1.89 (c = 0.98, CH3OH, 8.5% ee). Spectroscopic data are given in Tewes et al. (2015 ▸). Crystals of the title compound, suitable for X-ray diffraction analysis, were obtained by recrystallization from EtOAc.

Refinement details

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The OH and C-bound H atoms were included in calculated positions and treated as riding atoms: O—H = 0.83 Å, C—H = 0.94–0.99 Å with U iso(H) = 1.5U eq(O or C-meth­yl) and 1.2U eq(C) for other H atoms.
Table 2

Experimental details

Crystal data
Chemical formulaC25H27NO4S
M r 437.54
Crystal system, space groupOrthorhombic, P b c a
Temperature (K)223
a, b, c (Å)7.5071 (2), 23.6113 (8), 24.5180 (8)
V3)4345.9 (2)
Z 8
Radiation typeCu Kα
μ (mm−1)1.59
Crystal size (mm)0.25 × 0.15 × 0.08
 
Data collection
DiffractometerNonius KappaCCD APEXII
Absorption correctionMulti-scan (DENZO; Otwinowski et al., 2003)
T min, T max 0.692, 0.884
No. of measured, independent and observed [I > 2σ(I)] reflections40664, 3874, 3543
R int 0.064
(sin θ/λ)max−1)0.600
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.058, 0.151, 1.10
No. of reflections3874
No. of parameters283
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.64, −0.27

Computer programs: COLLECT (Nonius, 1998 ▸), DENZO–SMN (Otwinowski & Minor, 1997 ▸), SHELXS97, SHELXL97 and XP in SHELXTL (Sheldrick, 2008 ▸), Mercury (Macrae et al., 2008 ▸) and PLATON (Spek, 2009 ▸).

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2056989016005855/su5286sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989016005855/su5286Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989016005855/su5286Isup3.cml CCDC reference: 1472947 Additional supporting information: crystallographic information; 3D view; checkCIF report
C25H27NO4SF(000) = 1856
Mr = 437.54Dx = 1.337 Mg m3
Orthorhombic, PbcaCu Kα radiation, λ = 1.54178 Å
Hall symbol: -P 2ac 2abCell parameters from 5365 reflections
a = 7.5071 (2) Åθ = 0.9–68.3°
b = 23.6113 (8) ŵ = 1.59 mm1
c = 24.5180 (8) ÅT = 223 K
V = 4345.9 (2) Å3Plate, colourless
Z = 80.25 × 0.15 × 0.08 mm
Nonius KappaCCD APEXII diffractometer3874 independent reflections
Radiation source: fine-focus sealed tube3543 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.064
ω and φ scansθmax = 67.7°, θmin = 4.2°
Absorption correction: multi-scan (DENZO; Otwinowski et al., 2003)h = 0→9
Tmin = 0.692, Tmax = 0.884k = 0→27
40664 measured reflectionsl = 0→29
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.058Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.151H-atom parameters constrained
S = 1.10w = 1/[σ2(Fo2) + (0.0619P)2 + 5.5349P] where P = (Fo2 + 2Fc2)/3
3874 reflections(Δ/σ)max = 0.001
283 parametersΔρmax = 0.64 e Å3
0 restraintsΔρmin = −0.27 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C1−0.2632 (4)0.25588 (13)0.33843 (12)0.0433 (7)
H1−0.33270.26140.30450.052*
C2−0.0688 (4)0.26290 (13)0.32342 (11)0.0444 (7)
H2−0.04620.23830.29140.053*
N30.0518 (3)0.24359 (10)0.36757 (9)0.0382 (5)
C40.0510 (4)0.27343 (13)0.42068 (11)0.0448 (7)
H4A0.06560.31410.41420.054*
H4B0.15300.26050.44230.054*
C5−0.1175 (4)0.26389 (14)0.45294 (11)0.0480 (7)
H5A−0.09340.27210.49140.058*
H5B−0.15040.22380.45020.058*
C6−0.2745 (4)0.29959 (12)0.43450 (11)0.0408 (6)
C7−0.3588 (4)0.33478 (12)0.47111 (11)0.0403 (6)
H7−0.31620.33690.50710.048*
C8−0.5061 (4)0.36736 (11)0.45600 (10)0.0360 (6)
C9−0.5624 (4)0.36714 (11)0.40220 (11)0.0384 (6)
H9−0.65740.39020.39090.046*
C10−0.4758 (4)0.33218 (12)0.36548 (11)0.0415 (7)
H10−0.51360.33220.32890.050*
C11−0.3365 (4)0.29737 (12)0.38014 (11)0.0411 (6)
O12−0.2846 (3)0.19835 (9)0.35386 (10)0.0508 (6)
H12−0.38730.19330.36550.076*
C13−0.0263 (5)0.32466 (13)0.30574 (13)0.0515 (8)
H13A−0.04120.34980.33670.077*
H13B−0.10670.33590.27670.077*
H13C0.09560.32680.29280.077*
O14−0.5837 (3)0.39821 (8)0.49686 (7)0.0425 (5)
C15−0.7379 (4)0.43106 (13)0.48158 (12)0.0459 (7)
H15A−0.82730.40650.46460.055*
H15B−0.70390.46030.45510.055*
C16−0.8140 (4)0.45824 (12)0.53175 (11)0.0393 (6)
C17−0.9211 (4)0.42782 (14)0.56697 (13)0.0520 (8)
H17−0.94280.38920.56050.062*
C18−0.9964 (5)0.45419 (17)0.61180 (14)0.0611 (9)
H18−1.06920.43340.63570.073*
C19−0.9651 (5)0.51087 (16)0.62151 (13)0.0582 (9)
H19−1.01680.52870.65190.070*
C20−0.8587 (4)0.54114 (13)0.58683 (12)0.0499 (8)
H20−0.83680.57970.59360.060*
C21−0.7835 (4)0.51513 (12)0.54197 (12)0.0424 (7)
H21−0.71100.53620.51820.051*
S220.22307 (9)0.20715 (3)0.34775 (3)0.0364 (2)
O230.3341 (2)0.19811 (9)0.39487 (8)0.0422 (5)
O240.3039 (3)0.23240 (9)0.30048 (8)0.0447 (5)
C260.1770 (4)0.12036 (12)0.27553 (12)0.0431 (7)
H260.23490.14340.24980.052*
C270.1279 (4)0.06527 (13)0.26233 (12)0.0483 (7)
H270.15440.05110.22740.058*
C280.0412 (4)0.03100 (13)0.29945 (12)0.0476 (7)
C31−0.0091 (6)−0.02894 (14)0.28515 (16)0.0657 (10)
H31A−0.0590−0.02990.24870.099*
H31B−0.0968−0.04270.31100.099*
H31C0.0960−0.05280.28660.099*
C290.0012 (4)0.05326 (14)0.35077 (12)0.0512 (8)
H29−0.05910.03060.37630.061*
C300.0483 (4)0.10756 (14)0.36461 (12)0.0467 (7)
H300.01930.12220.39920.056*
C250.1392 (3)0.14065 (12)0.32714 (11)0.0373 (6)
U11U22U33U12U13U23
C10.0446 (16)0.0458 (16)0.0396 (14)0.0026 (13)−0.0051 (13)−0.0044 (12)
C20.0442 (16)0.0598 (18)0.0294 (13)0.0093 (14)−0.0050 (12)−0.0057 (12)
N30.0338 (11)0.0522 (14)0.0287 (11)0.0052 (10)−0.0015 (9)−0.0057 (10)
C40.0424 (16)0.0570 (18)0.0349 (14)0.0026 (14)−0.0042 (12)−0.0040 (13)
C50.0465 (17)0.065 (2)0.0320 (14)0.0151 (15)0.0018 (13)0.0027 (13)
C60.0420 (15)0.0484 (16)0.0322 (14)0.0081 (13)−0.0002 (12)−0.0002 (12)
C70.0445 (16)0.0467 (15)0.0295 (13)0.0076 (13)−0.0026 (12)0.0003 (11)
C80.0392 (14)0.0344 (13)0.0345 (13)0.0005 (12)0.0011 (11)−0.0008 (10)
C90.0397 (15)0.0369 (14)0.0387 (14)0.0057 (12)−0.0057 (12)0.0002 (11)
C100.0465 (16)0.0453 (16)0.0328 (13)0.0080 (13)−0.0084 (12)−0.0028 (11)
C110.0399 (15)0.0465 (16)0.0368 (14)0.0039 (13)−0.0019 (12)−0.0005 (12)
O120.0405 (12)0.0410 (11)0.0709 (15)−0.0013 (9)−0.0018 (11)−0.0050 (10)
C130.0531 (18)0.0531 (18)0.0483 (17)0.0045 (15)0.0078 (15)0.0148 (14)
O140.0424 (11)0.0503 (11)0.0346 (10)0.0144 (9)−0.0010 (8)−0.0037 (8)
C150.0469 (16)0.0475 (16)0.0432 (15)0.0129 (14)−0.0060 (13)−0.0047 (13)
C160.0356 (14)0.0421 (15)0.0401 (14)0.0084 (12)−0.0039 (12)−0.0004 (12)
C170.0545 (19)0.0481 (17)0.0533 (18)−0.0031 (15)−0.0016 (15)0.0022 (14)
C180.0516 (19)0.082 (3)0.0494 (19)−0.0063 (18)0.0107 (15)0.0127 (17)
C190.0538 (19)0.078 (2)0.0425 (17)0.0188 (18)0.0036 (15)−0.0082 (16)
C200.0566 (19)0.0456 (17)0.0473 (17)0.0131 (15)−0.0035 (15)−0.0065 (13)
C210.0411 (16)0.0430 (15)0.0432 (15)0.0047 (13)0.0000 (12)0.0006 (12)
S220.0295 (3)0.0466 (4)0.0330 (3)0.0008 (3)0.0022 (3)−0.0022 (3)
O230.0300 (9)0.0565 (12)0.0401 (10)0.0032 (9)−0.0036 (8)−0.0038 (9)
O240.0428 (11)0.0533 (12)0.0379 (10)−0.0057 (9)0.0086 (9)−0.0006 (9)
C260.0448 (16)0.0470 (16)0.0374 (14)−0.0002 (13)0.0059 (12)0.0012 (12)
C270.0576 (19)0.0493 (17)0.0380 (16)0.0012 (15)0.0049 (14)−0.0051 (13)
C280.0494 (17)0.0473 (16)0.0461 (16)−0.0006 (14)−0.0014 (14)−0.0003 (13)
C310.084 (3)0.0484 (19)0.065 (2)−0.0099 (18)0.003 (2)−0.0034 (16)
C290.0523 (19)0.0571 (19)0.0443 (17)−0.0119 (16)0.0052 (14)0.0047 (14)
C300.0468 (17)0.0580 (18)0.0354 (14)−0.0075 (14)0.0084 (13)−0.0043 (13)
C250.0313 (13)0.0460 (15)0.0347 (13)0.0014 (12)0.0012 (11)−0.0004 (12)
C1—O121.419 (4)C15—C161.500 (4)
C1—C21.514 (4)C16—C171.381 (4)
C1—C111.519 (4)C16—C211.386 (4)
C2—N31.483 (3)C17—C181.384 (5)
C2—C131.554 (4)C18—C191.379 (5)
N3—C41.480 (3)C19—C201.368 (5)
N3—S221.622 (2)C20—C211.380 (4)
C4—C51.509 (4)S22—O241.438 (2)
C5—C61.518 (4)S22—O231.441 (2)
C6—C71.377 (4)S22—C251.765 (3)
C6—C111.413 (4)C26—C251.382 (4)
C7—C81.397 (4)C26—C271.390 (4)
C8—O141.369 (3)C27—C281.381 (4)
C8—C91.385 (4)C28—C291.396 (4)
C9—C101.384 (4)C28—C311.506 (4)
C10—C111.377 (4)C29—C301.373 (4)
O14—C151.443 (3)C30—C251.386 (4)
O12—C1—C2106.2 (2)C17—C16—C21119.2 (3)
O12—C1—C11113.4 (2)C17—C16—C15120.8 (3)
C2—C1—C11116.3 (3)C21—C16—C15120.0 (3)
N3—C2—C1112.2 (2)C16—C17—C18120.0 (3)
N3—C2—C13111.5 (2)C19—C18—C17120.2 (3)
C1—C2—C13111.6 (3)C20—C19—C18120.0 (3)
C4—N3—C2119.5 (2)C19—C20—C21120.1 (3)
C4—N3—S22121.29 (18)C20—C21—C16120.5 (3)
C2—N3—S22115.37 (17)O24—S22—O23117.62 (12)
N3—C4—C5113.2 (2)O24—S22—N3110.87 (12)
C4—C5—C6114.3 (2)O23—S22—N3107.28 (11)
C7—C6—C11119.1 (3)O24—S22—C25106.78 (12)
C7—C6—C5119.9 (2)O23—S22—C25107.70 (12)
C11—C6—C5121.1 (2)N3—S22—C25105.96 (13)
C6—C7—C8121.5 (2)C25—C26—C27118.9 (3)
O14—C8—C9124.7 (2)C28—C27—C26121.3 (3)
O14—C8—C7115.8 (2)C27—C28—C29118.3 (3)
C9—C8—C7119.5 (2)C27—C28—C31121.0 (3)
C10—C9—C8118.6 (3)C29—C28—C31120.6 (3)
C11—C10—C9122.9 (3)C30—C29—C28121.3 (3)
C10—C11—C6118.3 (3)C29—C30—C25119.3 (3)
C10—C11—C1119.0 (3)C26—C25—C30120.8 (3)
C6—C11—C1122.6 (3)C26—C25—S22119.8 (2)
C8—O14—C15116.0 (2)C30—C25—S22119.2 (2)
O14—C15—C16108.8 (2)
O12—C1—C2—N3−53.8 (3)O14—C15—C16—C17−80.1 (3)
C11—C1—C2—N373.3 (3)O14—C15—C16—C21102.7 (3)
O12—C1—C2—C13−179.8 (2)C21—C16—C17—C180.0 (5)
C11—C1—C2—C13−52.6 (3)C15—C16—C17—C18−177.2 (3)
C1—C2—N3—C4−64.1 (3)C16—C17—C18—C190.0 (5)
C13—C2—N3—C461.9 (3)C17—C18—C19—C20−0.2 (5)
C1—C2—N3—S22137.5 (2)C18—C19—C20—C210.3 (5)
C13—C2—N3—S22−96.4 (3)C19—C20—C21—C16−0.3 (5)
C2—N3—C4—C569.7 (3)C17—C16—C21—C200.1 (4)
S22—N3—C4—C5−133.3 (2)C15—C16—C21—C20177.4 (3)
N3—C4—C5—C6−79.2 (3)C4—N3—S22—O24−114.3 (2)
C4—C5—C6—C7−123.1 (3)C2—N3—S22—O2443.7 (2)
C4—C5—C6—C1156.9 (4)C4—N3—S22—O2315.4 (3)
C11—C6—C7—C81.3 (4)C2—N3—S22—O23173.3 (2)
C5—C6—C7—C8−178.6 (3)C4—N3—S22—C25130.2 (2)
C6—C7—C8—O14176.6 (3)C2—N3—S22—C25−71.8 (2)
C6—C7—C8—C9−4.1 (4)C25—C26—C27—C280.7 (5)
O14—C8—C9—C10−177.5 (3)C26—C27—C28—C290.8 (5)
C7—C8—C9—C103.2 (4)C26—C27—C28—C31−179.1 (3)
C8—C9—C10—C110.3 (5)C27—C28—C29—C30−0.8 (5)
C9—C10—C11—C6−3.1 (5)C31—C28—C29—C30179.1 (3)
C9—C10—C11—C1173.4 (3)C28—C29—C30—C25−0.8 (5)
C7—C6—C11—C102.2 (4)C27—C26—C25—C30−2.3 (4)
C5—C6—C11—C10−177.9 (3)C27—C26—C25—S22172.5 (2)
C7—C6—C11—C1−174.1 (3)C29—C30—C25—C262.4 (5)
C5—C6—C11—C15.8 (5)C29—C30—C25—S22−172.4 (2)
O12—C1—C11—C10−116.8 (3)O24—S22—C25—C267.2 (3)
C2—C1—C11—C10119.7 (3)O23—S22—C25—C26−120.0 (2)
O12—C1—C11—C659.5 (4)N3—S22—C25—C26125.5 (2)
C2—C1—C11—C6−64.0 (4)O24—S22—C25—C30−177.9 (2)
C9—C8—O14—C151.8 (4)O23—S22—C25—C3054.9 (3)
C7—C8—O14—C15−178.9 (2)N3—S22—C25—C30−59.7 (3)
C8—O14—C15—C16175.5 (2)
D—H···AD—HH···AD···AD—H···A
O12—H12···O23i0.832.223.034 (3)169
C2—H2···O24ii0.992.523.265 (3)132
C18—H18···Cg3iii0.942.893.738 (4)150
C20—H20···Cg1iv0.942.833.631 (3)144
C29—H29···Cg2v0.942.763.545 (3)142
  18 in total

1.  Multiparametric scaling of diffraction intensities.

Authors:  Zbyszek Otwinowski; Dominika Borek; Wladyslaw Majewski; Wladek Minor
Journal:  Acta Crystallogr A       Date:  2003-04-25       Impact factor: 2.290

Review 2.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

Review 3.  NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore.

Authors:  István Borza; György Domány
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

Review 4.  Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Authors:  Laetitia Mony; James N C Kew; Martin J Gunthorpe; Pierre Paoletti
Journal:  Br J Pharmacol       Date:  2009-07-08       Impact factor: 8.739

5.  Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.

Authors:  Bastian Tewes; Bastian Frehland; Dirk Schepmann; Kai-Uwe Schmidtke; Thomas Winckler; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2010-05-03       Impact factor: 3.466

Review 6.  Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action.

Authors:  K Williams
Journal:  Curr Drug Targets       Date:  2001-09       Impact factor: 3.465

7.  Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.

Authors:  Bastian Tewes; Bastian Frehland; Dirk Schepmann; Kai-Uwe Schmidtke; Thomas Winckler; Bernhard Wünsch
Journal:  Bioorg Med Chem       Date:  2010-09-24       Impact factor: 3.641

8.  Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist.

Authors:  Evamaria Falck; Frank Begrow; Eugen Verspohl; Bernhard Wünsch
Journal:  J Pharm Biomed Anal       Date:  2013-08-21       Impact factor: 3.935

9.  Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.

Authors:  Erkan Karakas; Noriko Simorowski; Hiro Furukawa
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.